Search

Legend Biotech Corp ADR

Cerrado

SectorSanidad

17.57 0.11

Resumen

Variación precio

24h

Actual

Mínimo

17.18

Máximo

17.84

Métricas clave

By Trading Economics

Ingresos

88M

33M

Ventas

82M

388M

BPA

0.09

Margen de beneficios

8.568

Empleados

3,200

EBITDA

92M

60M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+160.84% upside

Dividendos

By Acuity

Próximas Ganancias

11 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-393M

3.6B

Apertura anterior

17.46

Cierre anterior

17.57

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

321 / 339 Clasificación en Healthcare

Legend Biotech Corp ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 sept 2026, 23:46 UTC

Legend Biotech Corp saw a modest increase in after-market trading, though it remains significantly below its 20-day moving average.

16 sept 2026, 20:10 UTC

News

Legend Biotech Corp shares fell sharply today despite reporting second-quarter CARVYKTI sales of $657 million, marking the tenth consecutive session of declines.

15 sept 2026, 22:02 UTC

Legend Biotech shares were roughly flat in after-market hours, remaining significantly below their 20-day moving average after nine consecutive lower sessions.

14 sept 2026, 19:36 UTC

Shares of Legend Biotech Corp are lower today, continuing a broader trend. The stock remains significantly below its 20-day moving average.

11 sept 2026, 23:26 UTC

Legend Biotech Corp shares are higher in after-market trading, reflecting notable gains since Friday's close amid speculation about Federal Reserve interest rate hikes.

9 sept 2026, 20:07 UTC

Legend Biotech Corp shares are lower, continuing a trend of four consecutive daily declines. The stock remains below its 20-day moving average.

8 sept 2026, 23:06 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, recovering from a recent decline that saw three consecutive lower closes.

3 sept 2026, 19:47 UTC

Shares of Legend Biotech Corp are lower today, despite earlier fluctuations that reached a session high. The stock remains above its 20-day moving average.

2 sept 2026, 20:03 UTC

News

Legend Biotech shares are higher as management discusses CARVYKTI's commercial rollout and plans to expand manufacturing capabilities at the Morgan Stanley Global Healthcare Conference.

1 sept 2026, 20:01 UTC

News

Legend Biotech will participate in the Morgan Stanley Global Healthcare Conference on September 15, 2026, as shares trade higher since Monday's close.

31 ago 2026, 22:16 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting a shift from recent higher daily closes amid broader market reactions to inflation comments from the Fed.

28 ago 2026, 20:07 UTC

Legend Biotech Corp shares are lower today, marking a fourth consecutive decline. Rising U.S. Treasury yields may be impacting investor sentiment.

27 ago 2026, 22:26 UTC

Legend Biotech Corp. shares are higher in after-market trading, gaining slightly since Thursday's close amid routine market fluctuations.

26 ago 2026, 23:11 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting the broader market's upward trend amid positive sentiment from major stocks.

25 ago 2026, 19:06 UTC

Shares of Legend Biotech Corp are higher today, remaining above their 20-day moving average amid positive market sentiment linked to falling oil prices.

24 ago 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, continuing a strong upward trend since Monday's close. The stock remains above its 20-day moving average.

21 ago 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, maintaining a position near the upper end of their one-month trading range.

20 ago 2026, 23:46 UTC

Legend Biotech Corp. shares are trading higher in after-market hours, diverging from broader market pressures amid rising crude oil prices and geopolitical tensions.

19 ago 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, showing notable strength and exceeding the 20-day moving average. No specific news was identified.

18 ago 2026, 20:03 UTC

Social Media

Legend Biotech Corp shares are higher today, buoyed by strong investor sentiment and analyst confidence in significant upside potential for the stock.

14 ago 2026, 19:36 UTC

Shares of Legend Biotech Corp are trading higher, though fluctuations have been routine during the session. The stock remains below its 20-day moving average.

13 ago 2026, 23:21 UTC

Legend Biotech Corp shares are higher in after-market hours, gaining traction following notable trading activity after Thursday's close. No specific news was identified.

12 ago 2026, 23:16 UTC

Legend Biotech Corp. shares are higher in after-market hours, reflecting positive market conditions amid a Consumer Price Index report that met forecasts.

11 ago 2026, 23:46 UTC

Shares of Legend Biotech Corp are higher in after-market hours, maintaining a position above the 20-day moving average amid stable trading conditions.

10 ago 2026, 23:06 UTC

Shares of Legend Biotech are higher in after-market trading, settling above Monday's close despite mixed market sentiment and geopolitical tensions.

7 ago 2026, 23:46 UTC

Shares of Legend Biotech Corp traded higher in after-market hours, amid a broader market context of a declining unemployment rate.

6 ago 2026, 20:06 UTC

Legend Biotech Corp shares are higher today, reflecting a shift from recent trends. No specific company news was identified to explain this movement.

4 ago 2026, 19:36 UTC

Legend Biotech Corp shares are higher today, recovering from an earlier low. Positive momentum persists despite a decline in U.S. core factory orders.

3 ago 2026, 22:01 UTC

Shares of Legend Biotech Corp are higher in after-market trading, reflecting gains since Monday's close amid broader market advances in tech and oil-sensitive sectors.

31 jul 2026, 23:56 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, despite a slight decline earlier in the session and broader market weakness.

Comparación entre iguales

Cambio de precio

Legend Biotech Corp ADR previsión

Precio Objetivo

By TipRanks

160.84% repunte

Estimación a 12 Meses

Media 45.856 USD  160.84%

Máximo 74 USD

Mínimo 24 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Legend Biotech Corp ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

9 ratings

5

Comprar

4

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Legend Biotech Corp ADR

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.